ARYx Therapeutics (ARYX)
|
0.0135
+0.0035 (+35.00%)
|
|
|
|
ARYX additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ARYX Profile
•
Exchange
NASDAQ
•
Held by these Mutual Funds
Prudential Jennison Health Sciences A
Pacific Select Health Sciences
CREF Stock
DFA US Small Cap I
DFA US Micro Cap I
LVIP SSgA Small Cap Index Standard
Vanguard Extended Market Idx
VALIC Company I Small Cap Index
CREF Equity Index
TIAA-CREF Small-Cap Blend Idx Inst
Pacific Select Health Sciences
CREF Stock
DFA US Small Cap I
DFA US Micro Cap I
LVIP SSgA Small Cap Index Standard
Vanguard Extended Market Idx
VALIC Company I Small Cap Index
CREF Equity Index
TIAA-CREF Small-Cap Blend Idx Inst
•
Competitors
•
Executives
Dr. Paul Goddard Ph.D.
Chairman and Chief Exec. Officer
Mr. John Varian
Chief Operating Officer
Mr. David Nagler
VP of Corp. Affairs and Sec.
Mr. Jason Barker r>Principal Accounting Officer and Sr. Director of Fin.
N/AN/A Winnie Tso CMA M
CPA
Corp. Controller
Chairman and Chief Exec. Officer
Mr. John Varian
Chief Operating Officer
Mr. David Nagler
VP of Corp. Affairs and Sec.
Mr. Jason Barker r>Principal Accounting Officer and Sr. Director of Fin.
N/AN/A Winnie Tso CMA M
CPA
Corp. Controller
•
Index Membership
N/A
•
Employee Count
56
Special Offers
Competitors
ARYX earnings
Date
Actual
Expected
Prev Yr Qtr
11/15/2010
-0.08
-0.09
-0.30
8/16/2010
-0.11
-0.10
-0.34
3/29/2010
-0.21
-0.23
-0.57
